Works matching Mifepristone
Results: 2205
Efficacy and safety of mifepristone-buccal misoprostol for early medical abortion in an Australian clinical setting.
- Published in:
- Australian & New Zealand Journal of Obstetrics & Gynaecology, 2017, v. 57, n. 3, p. 366, doi. 10.1111/ajo.12608
- By:
- Publication type:
- Article
Misoprostol-only versus mifepristone plus misoprostol in induction of labor following intrauterine fetal death.
- Published in:
- Acta Obstetricia et Gynecologica Scandinavica, 2007, v. 86, n. 6, p. 701, doi. 10.1080/00016340701379853
- By:
- Publication type:
- Article
KOMBINACIJA MIFEPRISTONA I MISOPROSTOLA U IZVOĐENJU MEDIKAMENTOZNOG ABORTUSA U PRVOM TRIMESTRU TRUDNOĆE.
- Published in:
- Medical Journal / Medicinski Časopis, 2021, v. 55, n. 4, p. 131, doi. 10.5937/mckg55-34879
- By:
- Publication type:
- Article
Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
- Published in:
- BJOG: An International Journal of Obstetrics & Gynaecology, 2009, v. 116, n. 3, p. 381, doi. 10.1111/j.1471-0528.2008.02034.x
- By:
- Publication type:
- Article
Roles of Mifepristone on the Regulation of Cytotoxic Lymphocytes and Regulatory T Cells.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Uterine Activity after Oral Mifepristone Administration in Human Pregnancies beyond 41 Weeks’ Gestation.
- Published in:
- Gynecologic & Obstetric Investigation, 2008, v. 65, n. 2, p. 112, doi. 10.1159/000109167
- By:
- Publication type:
- Article
Mifepristone Adverse Events Identified by Planned Parenthood in 2009 and 2010 Compared to Those in the FDA Adverse Event Reporting System and Those Obtained Through the Freedom of Information Act.
- Published in:
- Health Services Research & Managerial Epidemiology, 2021, v. 8, p. 1, doi. 10.1177/23333928211068919
- By:
- Publication type:
- Article
Mifepristone Adverse Events Identified by Planned Parenthood in 2009 and 2010 Compared to Those in the FDA Adverse Event Reporting System and Those Obtained Through the Freedom of Information Act.
- Published in:
- Health Services Research & Managerial Epidemiology, 2021, v. 8, p. 1, doi. 10.1177/23333928211068919
- By:
- Publication type:
- Article
Mifepristone Repairs Region-Dependent Alteration of Synapsin I in Hippocampus in Rat Model of Depression.
- Published in:
- Neuropsychopharmacology, 2007, v. 32, n. 12, p. 2500, doi. 10.1038/sj.npp.1301386
- By:
- Publication type:
- Article
Clinical and Biological Effects of Mifepristone Treatment for Psychotic Depression.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 3, p. 628, doi. 10.1038/sj.npp.1300884
- By:
- Publication type:
- Article
低剂量米非司酮联合戈舍瑞林注射液治疗子宫肌瘤患者效果 及对性激素水平的影响.
- Published in:
- Progress in Modern Biomedicine, 2023, v. 23, n. 12, p. 2320, doi. 10.13241/j.cnki.pmb.2023.12.022
- By:
- Publication type:
- Article
The efficacy of mifepristone combined with methotrexate for the treatment of ectopic pregnancy: a systematic review and meta-analysis*.
- Published in:
- Annals of Medicine, 2022, v. 54, n. 1, p. 3268, doi. 10.1080/07853890.2022.2136747
- By:
- Publication type:
- Article
Mifepristone decreases nicotine intake in dependent and non-dependent adult rats.
- Published in:
- Journal of Psychopharmacology, 2024, v. 38, n. 3, p. 280, doi. 10.1177/02698811241230255
- By:
- Publication type:
- Article
Mifepristone mediates anti-proliferative effect on ovarian mesenchymal stem/stromal cells from female BRCA<sup>1-/2-</sup> carriers.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Mifepristone priming and subsequent misoprostol for second trimester medical abortion in women with previous caesarean delivery.
- Published in:
- Australian & New Zealand Journal of Obstetrics & Gynaecology, 2023, v. 63, n. 3, p. 301, doi. 10.1111/ajo.13653
- By:
- Publication type:
- Article
Combination therapy with mifepristone and misoprostol for the management of first trimester miscarriage: Improved success.
- Published in:
- Australian & New Zealand Journal of Obstetrics & Gynaecology, 2018, v. 58, n. 4, p. 438, doi. 10.1111/ajo.12747
- By:
- Publication type:
- Article
Comparison of induction of labour regimes for termination of pregnancy, with and without mifepristone, from 20 to 41 weeks gestation.
- Published in:
- Australian & New Zealand Journal of Obstetrics & Gynaecology, 2017, v. 57, n. 6, p. 604, doi. 10.1111/ajo.12648
- By:
- Publication type:
- Article
Mifepristone increases AQP1 mRNA expression, angiogenesis, and cell permeability through the ERK MAPK pathway.
- Published in:
- Molecular Biology Reports, 2023, v. 50, n. 2, p. 1069, doi. 10.1007/s11033-022-08082-w
- By:
- Publication type:
- Article
Risk of teratogenicity in continued pregnancy after gestational exposure to mifepristone and/or misoprostol: a systematic review and meta-analysis.
- Published in:
- Archives of Gynecology & Obstetrics, 2024, v. 310, n. 3, p. 1331, doi. 10.1007/s00404-024-07616-w
- By:
- Publication type:
- Article
The indication and treatment outcome predictors of mifepristone treating ectopic pregnancy.
- Published in:
- Archives of Gynecology & Obstetrics, 2023, v. 308, n. 1, p. 143, doi. 10.1007/s00404-023-06998-7
- By:
- Publication type:
- Article
Dosing interval between mifepristone and misoprostol in second and third trimester termination.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Low-dose mifepristone increased angiogenesis in a manner involving AQP1.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Mifepristone vs balloon catheter for labor induction in previous cesarean: a randomized controlled trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Mifepristone combined with ethacridine lactate for the second-trimester pregnancy termination in women with placenta previa and/or prior cesarean deliveries.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Mifepristone and misoprostol is safe and effective method in the second-trimester pregnancy termination.
- Published in:
- Archives of Gynecology & Obstetrics, 2016, v. 294, n. 6, p. 1243, doi. 10.1007/s00404-016-4169-8
- By:
- Publication type:
- Article
Effects Mifepristone on Aminotransferase Activities in the Liver in Rats with Streptozotocin-Induced Diabetes Mellitus.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2018, v. 165, n. 4, p. 474, doi. 10.1007/s10517-018-4197-4
- By:
- Publication type:
- Article
Mifepristone for induction of labor.
- Published in:
- Translational & Clinical Medicine - Georgian Medical Journal, 2020, v. 5, n. 2, p. 52
- By:
- Publication type:
- Article
Comparing Mifepristone with Misoprostol combination to Misoprostol alone for labour induction in antepartum stillbirth.
- Published in:
- Caspian Journal of Reproductive Medicine, 2023, v. 9, n. 2, p. 9
- By:
- Publication type:
- Article
The Use of Methotrexate and Mifepristone for Treatment of Interstitial Pregnancies: An Overview of Effectiveness and Complications.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 23, p. 7396, doi. 10.3390/jcm12237396
- By:
- Publication type:
- Article
Direct Effects of Mifepristone on Mice Embryogenesis: An In Vitro Evaluation by Single-Embryo RNA Sequencing Analysis.
- Published in:
- Biomedicines, 2023, v. 11, n. 3, p. 907, doi. 10.3390/biomedicines11030907
- By:
- Publication type:
- Article
The effects of mifepristone on the structure of human decidua and chorion and Bax and Bcl-2 expression at early stage of pregnancy.
- Published in:
- BMC Pharmacology & Toxicology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s40360-022-00592-4
- By:
- Publication type:
- Article
The effects of mifepristone on the structure of human decidua and chorion and Bax and Bcl-2 expression at early stage of pregnancy.
- Published in:
- BMC Pharmacology & Toxicology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s40360-022-00592-4
- By:
- Publication type:
- Article
Pharmacokinetics and bioequivalence of two formulations of mifepristone tablets in healthy Chinese subjects under fasting conditions: a single-center, open, randomized, single-dose, double-period, two-sequence, crossover trial.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1479205
- By:
- Publication type:
- Article
Mifepristone in fibroids: Comparative study of safety and efficacy of biweekly dosage vs daily dosage schedule.
- Published in:
- Journal of Mid-life Health, 2021, v. 12, n. 1, p. 39, doi. 10.4103/jmh.JMH_90_20
- By:
- Publication type:
- Article
Mifepristone therapy in symptomatic leiomyomata using a variable dose pattern with a favourable outcome.
- Published in:
- Journal of Mid-life Health, 2018, v. 9, n. 2, p. 65, doi. 10.4103/jmh.JMH_100_17
- By:
- Publication type:
- Article
Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman.
- Published in:
- Journal of Mid-life Health, 2013, v. 4, n. 1, p. 22, doi. 10.4103/0976-7800.109630
- By:
- Publication type:
- Article
Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases.
- Published in:
- Clinical Medicine Insights: Endocrinology & Diabetes, 2021, p. 1, doi. 10.1177/1179551421994102
- By:
- Publication type:
- Article
Histopathologic Characterization of Mifepristone-induced Ovarian Toxicity in Cynomolgus Monkeys.
- Published in:
- Toxicologic Pathology, 2018, v. 46, n. 3, p. 283, doi. 10.1177/0192623318763586
- By:
- Publication type:
- Article
"Clandestine" home delivery with mifepristone.
- Published in:
- Forensic Science, Medicine & Pathology, 2023, v. 19, n. 4, p. 563, doi. 10.1007/s12024-022-00561-7
- By:
- Publication type:
- Article
Association of the G2014G Genotype in Estrogen Receptor 1 Gene with Failure of the Mifepristone-Induced Termination of Early Pregnancy.
- Published in:
- Tohoku Journal of Experimental Medicine, 2010, v. 220, n. 1, p. 77, doi. 10.1620/tjem.220.77
- By:
- Publication type:
- Article
Access to mifepristone, misoprostol, and contraceptive medicines in eight countries in the Eastern Mediterranean Region: descriptive analyses of country-level assessments.
- Published in:
- Reproductive Health, 2024, v. 20, n. 1, p. 1, doi. 10.1186/s12978-024-01805-1
- By:
- Publication type:
- Article
Antitumor effect of mifepristone on human endometrial stromal cell line.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2021, v. 78, n. 6, p. 615, doi. 10.2298/VSP190226104L
- By:
- Publication type:
- Article
Medikamentni abortus mifepristonom i misoprostolom u Srbiji i Crnoj Gori.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2006, v. 63, n. 6, p. 558
- By:
- Publication type:
- Article
A Comparative Study between Mifepristone Vs. Placebo as an Uterine Sensitizer for Second Trimester Abortions.
- Published in:
- National Journal of Medical Research, 2019, v. 9, n. 4, p. 145
- By:
- Publication type:
- Article
Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers.
- Published in:
- Pilot & Feasibility Studies, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1186/s40814-019-0520-8
- By:
- Publication type:
- Article
Conditional Inhibition of Eip75B Eliminates the Effects of Mating and Mifepristone on Lifespan in Female Drosophila.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 13, p. 1123, doi. 10.3390/cells13131123
- By:
- Publication type:
- Article
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 21, p. 3482, doi. 10.3390/cells11213482
- By:
- Publication type:
- Article
A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones.
- Published in:
- BJU International, 2008, v. 101, n. 9, p. 1084, doi. 10.1111/j.1464-410X.2008.07509.x
- By:
- Publication type:
- Article
Mifepristone-induced abortion and duration of third stage labour in a subsequent pregnancy.
- Published in:
- Paediatric & Perinatal Epidemiology, 2010, v. 24, n. 2, p. 125, doi. 10.1111/j.1365-3016.2010.01102.x
- By:
- Publication type:
- Article
Mifepristone increases gamma-retroviral infection efficiency by enhancing the integration of virus into the genome of infected cells.
- Published in:
- Gene Therapy, 2010, v. 17, n. 10, p. 1253, doi. 10.1038/gt.2010.80
- By:
- Publication type:
- Article